1. Home
  2. SHO vs GENB Comparison

SHO vs GENB Comparison

Compare SHO & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

N/A

Current Price

$11.31

Market Cap

2.0B

ML Signal

N/A

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$13.96

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SHO
GENB
Founded
1995
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
SHO
GENB
Price
$11.31
$13.96
Analyst Decision
Buy
Strong Buy
Analyst Count
12
6
Target Price
$11.96
★ $27.00
AVG Volume (30 Days)
★ 1.6M
1.0M
Earning Date
11-06-2026
11-03-2026
Dividend Yield
★ 3.21%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.22
N/A
Revenue
★ $1,115,167,000.00
N/A
Revenue This Year
$2.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$50.80
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$8.69
$11.00
52 Week High
$12.07
$22.67

Technical Indicators

Market Signals
Indicator
SHO
GENB
Relative Strength Index (RSI) 49.85 43.15
Support Level $10.99 $14.89
Resistance Level $11.19 $15.05
Average True Range (ATR) 0.17 0.88
MACD 0.03 -0.22
Stochastic Oscillator 57.58 9.23

Price Performance

Historical Comparison
SHO
GENB

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: